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INTRODUCTION
Peripheral nerve blocks provide ideal operating conditions when used optimally. They 
are said to cause least interference with the vital physiological functions of the body and 
reduced stress response avoiding polypharmacy with an alert, awake and co-operative 
patient when compared to other conventional techniques. Adequately administered 
regional anaesthesia can not only provide excellent intraoperative pain relief  but also 
good post operative analgesia.
Regional anaesthesia traces its origin to Dr.Carl Koller, a young Viennese 
Opthalmologist, who in 1884 employed a solution of cocaine for topical corneal 
anaesthesia in patients undergoing eye surgeries. Most of the local anaesthetic agents 
developed in the first half of 20th century (1900 – 1940) were basically amino ester 
compounds. They lost their importance due to their shorter duration of action and 
associated allergic reactions and systemic toxicity. This paved the way for the synthesis 
of newer agents namely the aminoamide compounds. The advent of  long acting drugs 
have made it possible to carry out prolonged surgeries in the extremities especially for 
Vascular ,Orthopaedic and Plastic procedures and also for relief of chronic pain. The 
main drawbacks of these agents were the delayed onset of action, varying quality of 
blockade and inadequate post operative analgesia. To overcome these problems various 
additives were tried along with local anaesthetic solutions.
a
Brachial Plexus block1 was first performed by William Stewart Halsted in 1889. He 
directly exposed the brachial plexus in the neck to perform the block and used cocaine. 
Hirschel first described the percutaneous approach to the brachial plexus. Kulenkampff 
first described the classical supraclavicular approach to the brachial plexus. The 
subclavian perivascular block was first described by Winnie and Collins. The 
infraclavicular approach was first developed by Raj. The axillary approach was first 
performed by Accardo and Adriano in 1949. 
The demonstration of α-adrenorecepors in the Peripheral nervous system prompted 
many investigations on the effects of using various α-adrenergic drugs in combination 
with local anaesthetics for peripheral nerve blocks to prolong post operative analgesia.
The present study is designed to compare the efficacy of added alpha adrenergic 
agonist clonidine and epinephrine for prolongation of post operative analgesia when 
added to bupivacaine in the Brachial Plexus block.
AIM OF THE STUDY
The aim of the study is:
a. To compare the effects of  alpha adrenergic agonists Clonidine and adrenaline as 
an adjuvant to bupivacaine in blocking brachial plexus by supraclavicular approach 
in patients undergoing upper limb surgeries.
The following parameters are compared
* Onset of sensory and motor blockade
* Duration of sensory blockade
* Haemodynamic stablity
b. To study the associated complications of the procedure.
APPLIED PHYSIOLOGY
PHYSIOLOGY OF NERVE CONDUCTION: 2
Neurons are the basic building blocks of the nervous system that respond to various 
stimuli. Integration and transmission of nerve impulses are specialised functions of 
neurons.
All peripheral nerves are elongated axons of neurons situated centrally. A typical 
peripheral nerve consists of bundles of motor, sensory and other fibres enclosed in the 
outermost covering called epineurium. Inside the epineurium, the perineurium surrounds 
the collection of bundles. Each bundle is surrounded by an endoneurium. Each nerve 
fibre in a bundle is enclosed in a layer of neurilemma or the axonal membrane. 
Depending on the presence or absence of myelin sheath, it can be a myelinated 
nerve fibre or unmyelinated  nerve  fibre.
The axonal membrane itself is made up of a bimolecular lipid palisade, interspersed 
with large protein molecules. The membrane lipids are largely phospholipids composed 
of a polar head group and a non polar hydrocarbon tail.
The primary function of the cell membrane is to separate the extracellular from the 
intracellular environment. The major difference between these two environments is the 
ionic concentration. This disequilibrium provides the means for impulse conduction.
The most important ions in this respect are Sodium and Potassium. A membrane 
bound protein sodium potassium ATPase maintains normal 
resting equilibrium potential between -50mv to -90mv by pumping sodium ions out 
of the cell and potassium ions into the cell. A positive ion gradient from inside the 
membrane to the outside causes electro negativity  inside the membrane.
During nerve conduction the following changes occur in the cell membrane.
IN THE RESTING PHASE:
There is a potential difference across the membrane inside is negative, due to a 
higher concentration of Sodium ions outside than inside the cell. 
K+ moves out of cells and Na+ moves in but because of more K+ channels opened at 
rest, K+ permeability is greater than Na+ permeability. Therefore K+ channels maintain 
the resting membrane potential. 
DEPOLARIZATION PHASE:
During excitation, Na+ channels in the cell membrane open briefly allowing 
sodium ions to flow into the cell, thereby depolarizing the membrane.
REPOLARIZATION PHASE:
During this phase, opening of voltage gated K+ channel occurs, results in passing 
of Potassium ions out of the cell to restore electrical neutrality.
RESTORATION PHASE:
During this phase, sodium ions return to the outside and potassium ions re-enter 
the cell.
DISTRIBUTION OF ION CHANNELS IN MYELINATED NEURONS:
Voltage gated Na+ channels are highly concentrated in the nodes of Ranvier and the 
initial segment in myelinated neurons.
The initial segment and in sensory neurons, the first node of Ranvier are the sites 
where impulses are normally generated and the other nodes of Ranvier are the sites to 
which the impulses jump during saltatory conduction.
The sodium channel is believed to be an integral membrane spanning protein. The 
three dimensional configuration of the proteins forms a pore through the neuronal 
membrane.
Depolarization of the cell induces a configurational change on the sodium channel 
which causes it to open and allow ion passage.
In many myelinated neurons, the Na+ channels are flanked by K+ channels that are 
involved in repolarization.
ACTION OF LOCAL ANAESTHETICS ON NERVE FIBRES: 3
The primary action of local anaesthetics on the nerves is electrical stabilization. 
The large transient increase in permeability to Na+ ions necessary for propagation of the 
nerve impulse is prevented. Thus the 
resting membrane potential is maintained and depolarization in response to 
stimulation is inhibited.
Local anaesthetics block sodium conductance by:
1. Binding of local anaesthetics to sites on voltage gated Na+ channels prevents 
opening of the channels by inhibiting the conformational changes that underlie 
channel activation.
2. Local anaesthetics produce nonspecific membrane expansion. There is an 
unfolding of membrane protein together with a disordering of the lipid component 
of the cell membrane with consequent obstruction of the sodium channel.
Action of alpha adrenergic agonists on nerve fibres produces antinociception in a 
variety of ways.
a. The α-2 adrenoreceptors are located on the afferent terminals of both peripheral 
neurons and neurons in the superficial laminae of the spinal cord, and within 
several brainstem nuclei implicated in analgesia.
b. Clonidine partially inhibits voltage gated Na+ and K+ channels and suppresses the 
generation of action potentials in tonic firing neurons.
c. Some contribution by the release of acetylcholine in the neuraxial region.
d. Some degree of blockade by blocking the C-fibres in the peripheral nerves.
ANATOMY OF THE BRACHIAL PLEXUS
THE BRACHIAL PLEXUS: 6   FIG - 1
Brachial Plexus is one of the most commonly used peripheral nerve blocks in 
clinical practice. So knowledge of the formation of the brachial plexus and of its 
distribution is absolutely essential for the effective use of brachial plexus block for 
surgeries of the upper limb. Absolute familiarity with the Vascular, Muscular and fascial 
relationship of the brachial plexus throughout its formation and distribution is equally 
essential for the mastery of various techniques of brachial plexus anaesthesia.
In its course from the intervertebral foramina to the upper arm, the fibres that 
constitute the plexus are composed consecutively of roots, trunks, cords, divisions and 
terminal nerves which are formed through a complex process of combining, dividing, 
recombining and finally redividing.
FORMATION OF THE PLEXUS: 
ROOTS:
The plexus is formed by the anterior primary rami of 5th to 8th cervical plexus 
together with the bulk of the 1st thoracic nerve (C
8
-T
1
). In addition, there is frequently a 
combination from C
4
 to the 5th cervical roots and another below the T
2 
to the 1st 
thoracic nerve. Occasionally the plexus is mainly derived from C
4
-C
8
 (prefixed plexus) 
or from C
6
-T
2
 (post fixed plexus).
TRUNKS:
The five roots of the brachial plexus emerge from the intervertebral foramina. They 
lie in the gutter between the anterior and posterior tubercles of the corresponding 
transverse process. All five roots then become sandwiched between Scalenus anterior 
and Scalenus medius. Here the roots of C
5 
and C
6 
unite into the upper trunk, the root of 
C
7
 continues as the middle trunk and those of C
8
 and T
1
 into the lower trunk. Each trunk 
divides behind the clavicle, into anterior and posterior divisions which unite in the axilla 
to form cords.
CORDS:
The six divisions stream into axilla and there join up into three cords; lateral, 
medial and posterior. These cords are composed as follows:
The union of the anterior divisions of the Upper and middle trunks form the lateral 
cord. The medial cord represents the continuation of the anterior division of the lower 
trunk. The posterior cord comprises of the posterior divisions of all the three trunks. The 
composition of brachial plexus can be summarised as follows:
1. Five roots (between the scalene muscles) - the anterior primary rami of C
5
-C
8 
and 
T
1
.
2. Three trunks (in the posterior triangle)
a) Upper trunk C
5
 and C
6
b) Middle trunk C
7 
alone
 FIG - 3
c) Lower trunk C
8
 and T
1
 
3. Six divisions (behind the Clavicle)
Each trunk divides into an anterior and posterior division.
4. Three cords (within the axilla)
a) Lateral Cord - the fused anterior divisions of the upper and middle trunks C
5
 - 
C
7
b) Medial Cord - the anterior division of the lower trunk C
8
 - T
1
c) Posterior Cord formed by the union of the posterior divisions of all three trunks 
C
5
-T
1
RELATIONS OF THE BRACHIAL PLEXUS: FIG – 2 & 3
ROOTS:
Lie between the Scalenus anterior and Scalenus medius. The roots of the Plexus lie 
above the second part of the subclavian artery.
TRUNKS:
In the Posterior triangle, the trunks of the plexus invested in a sheath of 
prevertebral fascia, are superficially placed, being covered by skin, platysma and deep 
fascia.
The upper and middle  trunks lie above the subclavian artery as they stream across 
the first rib, but the lower trunk like behind the artery and may groove the rib 
immediately posterior to the subclavian groove.
i
DIVISIONS:
At the lateral border of the first rib, the trunks bifurcate into divisions which are 
situated behind the clavicle, subclavius muscle and the suprascapular vessels.
CORDS:
The cords are formed at the apex of the axilla and become grouped around the 
axillary artery.
THE INTERSCALENE SHEATH:
As the roots emerge in the groove between the transverse process of the tubercle, 
they lie in a fibrofatty space between two layers of fibrinous sheath. Posterior Sheath 
from the posterior tubercles covers the front of the medius, anterior sheath from anterior 
tubercles cover the posterior aspect of the Scalenus anterior. The sheath extends into the 
axilla around the plexus. Significance of this space is that the local anaesthetic can be 
injected to produce block at various sites by interscalene, subclavian perivascular or the 
axillary approach.
SYMPATHETIC SUPPLY: 
Close to the emergence the 5th and 6th Cervical nerves receive a grey ramus from 
the middle cervical sympathetic ganglion. The 7th and 8th cervical nerves each receive a 
grey ramus from the inferior cervical ganglion and from T1ganglion
BRANCHES:
Branches are given off from roots, trunks and cords.
B
1. Branches from the roots:
a) Nerve to the serratus anterior C
5
, C
6
 and C
7
b) Muscular branches to
- Longus cervices C
5
 - C
8
- Three Scalene C
5
 - C
8
- Rhomboids C
5
c) Twig to the Phrenic nerve C
5
2. Branches from the trunks:
a) Suprascapular nerve C
5
-C
6
b) Nerve to subclavius C
5
-C
6
3. Branches from the Cords:
a) Lateral Cord
- Lateral Pectoral nerve C
5
-C
7
- Lateral head of median nerve C
5
-C
7
- Musculocutaneous nerve
 
C
5
-C
7
7
b) Medial Cord
- Medial Pectoral nerve C
8
 - T
1
- Medial head of median nerve C
8
 - T
1
- Medial Cutaneous nerve of arm C
8
 - T
1
- Medial Cutaneous nerve of forearm C8 - T1
- Ulnar nerve of arm C7, C8 - T1
c) Posterior Cord
- Upper Subscapular nerve C
5
-C
6
- Lowe Subscapular nerve C
5
-C
6
- Nerve to latissimus dorsi C
6
, C
7,
 C8
- Axillary nerve C
5
-C
6
- Radial nerve C
5
, C
6, 
C
7
, C
8, 
T
1
ANATOMIC CONSIDERATIONS OF THE INTERSCALENE SPACE:
The roots of the brachial plexus, after leaving the transverse process of the 
corresponding cervical vertebrae, descend in between the scalenus anterior and medius 
in the posterior triangle of the neck.
Scalenus anterior arises from the anterior tubercles of the transverse processes of C
3 
- C
6
 Vertebrae. It is inserted into the scalene tubercle on the inner border of the first rib. 
The muscle lies anterior to the plexus and at its 
insertion lies anterior to the subclavian artery which separates the plexus from its 
insertion. Scalenus medius arises from the posterior tubercles of the six lowest cervical 
vertebrae and is inserted into the upper surface of the first rib behind the groove made by 
the brachial plexus and the subclavian artery. Thus the plexus lies in front of the muscle.
The first rib lies in an almost horizontal plane being inclined slightly downwards 
and forwards. It passes below the clavicle at about the junction of its inner and middle 
thirds. The upper surface of first rib has two transverse grooves - an anterior one for the 
subclavian vein and a posterior one for the subclavian artery and the lowest trunk of the 
brachial plexus. On the inner border between the grooves is the scalene tubercle.
Brachial line runs in a straight line from the transverse process of the C
6
 vertebra to 
the axillary artery in the axilla. It runs inferolaterally at an angle of 45degree from the 
horizontal plane and slightly forwards at 15 degree.
Techniques of Brachial Plexus Block:(1, 7)
Surgical anaesthesia of the upper extremity and shoulder can be achieved following 
neural blockade of the brachial plexus at various sites. The various approaches that can 
be used for this blockade is as follows: 
FIG - 4
i) Interscalene approach
ii) Supraclavicular approach
a) Classic approach
b) Plumb bob technique
c) Supraclavicular Perivascular technique
iii)  Axillary approach
iv) Infraclavicular approach
v) Posterior approach
INTERSCALENE BRACHIAL PLEXUS BLOCK
TECHNIQUE:
 In this technique plexus is blocked at the level of the C
6
 vertebra. By standing at 
the side of the patient and after locating the interscalene groove, an intradermal wheal is 
raised at the point of needle insertion which is at the level of the cricoid cartilage. A 22 
gauge 3.5 cm short bevel needle is inserted “at right angles to the skin in all planes” i.e. 
dorsal to the horizontal 
planes. The needle is advanced slowly until paraesthesia sought in the shoulder or a 
nerve stimulator is used to evoke contractions in the deltoid or biceps brachialis muscle. 
20 -40 ml of local anaesthetic injected after repeated aspiration to detect inadvertent 
entry into vertebral artery or dural cuff.
COMPLICATIONS:
1. Subarachnoid injection
2. Epidural blockade
3. Intravascular Injection
4. Pneumothorax
5.    Phrenic nerve block
SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK:
A. CLASSICAL SUPRACLAVICULAR BLOCK OF KULENKAMPFF:
In the classic approach, the needle insertion site is 1 cm superior to the clavicular 
midpoint. The needle is inserted in a plane parallel to the patient neck and head. The 
needle will contact the rib at a depth of 3 to 4 cm. The needle is walked over the rib until 
paraesthesia is elicited.  After careful aspiration the local anaesthetic is injected.
B. PLUMB BOB SUPRACLAVICULAR BLOCK:
The brachial plexus at the level of the first rib lies posterior and cephalic to the 
subclavian artery. Once this skin mark has been placed 
s
FIG – 5
immediately superior to the clavicle at the lateral border of the sternomastoid muscle as 
it is inserted into the clavicle, the needle is inserted at a 90 degree angle to the table top. 
The local anaesthesia is injected after eliciting paraestehsia. The name Plumb bob was 
chosen for this technique because if one suspends a Plumb bob over the entry site, 
needle inserted through that point will result in contact with the brachial plexus in most 
patients.
SUBCLAVIAN PERIVASCULAR TECHNIQUE OF WINNIE AND COLLINS: 
FIG - 5
The interscalene groove is palpated at its most inferior point, which is just posterior 
to the subclavian artery pulse. The needle is directed just above and posterior to the 
subclavian pulse and directed caudally at a flat angle against the skin. The needle is 
advanced until paraesthesia is elicited and the local anaesthetic is injected after careful 
aspiration.
COMPLICATIONS:
1. Pneumothorax
2. Horner’s syndrome
3. Phrenic nerve block
4. Haemothorax and Haematoma formation.
INFRACLAVICULAR TECHNIQUE:
This is the preferred technique for the surgeries of elbow and lower arm because 
spread of local anaesthetic is kept below the clavicle. This technique blocks the brachial 
plexus at the level of cords. The needle is 
inserted 1 inch beneath the midpoint of the clavicle. It is then directed laterally 
from this site at a 45 degree angle away from the chest wall and towards the humeral 
head or the coracoid process. Once paraethesia is elicited, the local anaesthetic is 
injected. 
COMPLICATIONS:
1. Pneumothorax
2. Haemothorax
3. Chylothorax with a left side block
AXILLARY BRACHIAL PLEXUS BLOCK:
The pulsations of the axillary artery are best felt high in the axilla between the 
coracobrachialis and pectoralis major muscle. The needle is inserted just superior to the 
artery until the resistance of the fascial sheath is felt and a pop indicated the correct 
needle placement.
COMPLICATIONS:
1. Intra arterial Injection
2. Post Operative neuropathy
3. Hematoma and Infection.
STRUCTURE OF BUPIVACAINE
PHARMACOLOGY OF BUPIVACAINE: (8, 9, 10, 11)
Bupivacaine is an aminoacyl amide synthetic local anaesthetic synthesised by AF 
EKENSTAM et al at AB Botors (1957)10. Clinically used by Telivuion in 1963. It is 
produced for clinical use as a racemic mixture of the enantiomer containing equal 
proportions of the S and R forms. 
  PHYSIOCHEMICAL PROPERTIES:
Bupivacaine has a butyl group on the piperidine nitrogen atom of the molecule. It is a 
long acting local anaesthetic drug with high anaesthetic potency. It is more lipids 
soluble, highly protein bound and has greater intrinsic potency. It is 3 to 4 times as 
potent as lignocaine. It crosses the placenta and the blood brain barrier.
1. Molecular weight base 288
2. Pka 8.1
3. Partition Coefficient 346
4. Mean uptake ratio 3.3
5. Protein binding 96%
PHARMACOLOGICAL PROPERTIES:
Onset Moderate
Relative Potency 8
Duration of action     360 -720Min. 11
 MECHANISM OF ACTION:
Bupivacaine produces electrical stabilisation of the membrane by dual action on 
sodium conductance.
1. Acts directly on the receptors within the sodium channels.
2. Produces non specific membrane expansion.
PHARMACOLOGICAL EFFECTS:
a. Local Nerve blockade
b. Regional Pain, temperature, touch, motor power and 
vasomotor tone in the region supplied by the nerves are 
blocked
c. Systemic Effects occuring as a result of systemic absorption 
or intravenous administration. 
On the cardiovascular system, the effect of bupivacaine is dose related. It depresses 
the automaticity of the heart and myocardial contractility. Depending on the membrane 
potential and the rate of stimulation, Bupivacaine depresses Vmax considerably more 
than lignocaine and results in slowed conduction of the cardiac action potential which is 
manifested as the prolongation of the PR and QR intervals on the electrocardiogram. 
This results in reentrant phenomenon and ventricular arrhythmias. The Na+ channels are 
blocked in a fast - in slow-out manner which causes difficulty in resuscitation when the 
ventricular fibrillation has occured. The Cardiotoxicity of bupivacaine results from high 
lipid solubility and the R enantiomer is more toxic than the S enantiomer.
 The Bupivacaine depresses the rapid phase of depolarisation (Vmax) in Purkinje 
fibres and Ventricular Muscle to a greater extent than lidocaine does. The CC/CNS dose 
ratio for Bupivacaine was 3.7+0.5.
PHARMACOKINETICS: 12
Volume of distribution at steady state: 72 litres
Terminal elimination half life : 210 minutes
Clearance : 0.47 litres/minutes
Metabolism : Liver by dealkylation to
Pipecolyloxilidine
Excretion : 5% by the kidney as      unchanged 
drug and the rest as metabolites.
DRUG DOSAGE: (13.14)
Plain Bupivacaine               up to 2.5 mg/kg
  Bupivacaine added with epinephrine-3 mg/kg.
STRUCTURE OF CLONIDINE
PHARMACOLOGY OF CLONIDINE
Clonidine hydrochloride is an imidazoline derivative with α-2 adrenergic agonist 
that has a variety of different actions including antihypertensive effects as well as the 
ability to potentiate the effects of local anaesthetic. It can provide pain relief by an 
opioid -independent mechanism.
MECHANISM OF ACTION: 15
Clonidine is a selective partial α
2
 adrenergic agonist with a selectivity ratio of about 
200: 1 in favour of α
2
 receptors. It is lipid soluble and easily penetrates the blood brain 
barrier to reach the hypothalamus and medulla when injected epidurally.
- It stimulates inhibitory α
2
 adrenoreceptors to reduce central neural transmission in 
the spinal nerves.
- Inhibition of substance P release is believed to be involved in the analgesic effect.
α
2
 - adrenoreceptors are located on the afferent terminals of both peripheral neurons 
and neurons in the superficial laminae of the spinal cord and within several brainstem 
nuclei implicated in analgesia.
HYPOTHESIS OF ANALGESIC ACTION OF CLONIDINE IN SPINAL CORD: 
16
The superficial laminae of the dorsal horn contain 3 groups of neurons:  tonic, 
adapting and single-spike firing; all of which are important neuronal 
structures for pain transmission, receiving most of their primary sensory input from 
Aδ and C fibres. Clonidine partially inhibits voltage gated Na+ and K+ channels and 
suppresses the generation of action potentials in tonic-firing dorsal horn spinal neurons.
Some contribution to the analgesic effect of Clonidine may be through release of 
Ach in the neuraxial region.
PHARMACOKINETICS: (17, 18, 19, 20)
Clonidine is relatively well absorbed by most routes. Concentrations in blood peak 
in 2 -4 hours after oral clonidine. It is a lipid soluble drug rapidly crosses blood brain 
barrier. About 20 - 40% of the drug bound to plasma proteins. The volume of 
distribution is 150L /70 kg (2.1 +0.4L/kg). The plasma clearance is 12.6L/hr/70 kg. 1/2 
to 2/3 of an oral dose is excreted unchanged in urine, the rest as metabolites 
P.hydroxyclonidine. 60 -70% of the parent drug is excreted in the urine. Plasma t ½ 
8-12 hrs. Effect of single dose lasts for 6 - 24 hours.
Elimination t1/2 9+ 2 hrs. It is severely affected in severe renal dysfunction. (41 
hour)
PHARMACOLOGICAL ACTIONS: (17, 18, 19, 20, 21)
CARDIOVASCULAR SYSTEM:
Stimulation of α
2
A receptors present mainly post junctionally in medulla 
(Vasomotor centre) decreases sympathetic outflow leads to reduced release of 
norepinephrine causes fall in BP and bradycardia (also due to enhanced vagal tone). This 
activation of the Post synaptic α
2
 adrenoreceptors in the Nucleus Tractus Solitarius and 
locus ceruleus of the 
brain stem reduces sympathetic drive. It also activates non -adrenergic imidazoline 
preferring binding sites in the lateral reticular neucleus thereby producing hypotension 
and an anti arrhythmogenic actions.
CENTRAL NERVOUS SYSTEM:
 Being lipophilic it crosses blood brain barrier rapidly and cause analgesic action by 
its action with in several brain nuclei.
Sedation is a dose dependent response of clonidine by its action in the locus 
ceruleus
RESPIRATORY SYSTEM:
Not induce Respiratory depression even after massive overdose nor they potentiate 
respiratory depression from opioids.
PERIPHERAL NERVES:
Some preference over C fibres in the peripheral nerve may enhance peripheral 
nerve block when added to local anaesthetics
RENAL:
Dose should be adjusted according to the degree of renal impairment Decreased 
sympathetic flow to the kidney results in reduced renin release
PREPARATIONS AVAILABLE: 19
Oral 0.1, 0.2, 0.3 mg tablet
IV 150 µg /ml preservative free
Transdermal patches 0.1, 0.2, 0.3 mg /24 hrs
0
DOSE:
For Peripheral Nerve block 1-2 µg/kg body wt (22, 23).
  Intrathecally - 15-30 µg (up to 1µg/kg body weight)
  Epidural dose 1-2 µg/kg bodyweight as continuous infusion  
  For epidural bolus dose 6-8 µg/kg bodyweight.
Intraarticular dose is 2 µg/kg bodyweight.
Oral 4-5 µg/kg
Intramuscular 2 µg/kg
Intravenous 4-8 µg/kg i.v bolus 2 µg/kg/hr continuous infusion
 USE IN OBSTETRICS AND LACTATION:
Clonidine readily crosses the placental barrier and may lower the fetal heart rate. 
Maternal perfusion of the placenta is critically dependent on blood pressure so use of 
clonidine as an analgesic during labor and delivery is not indicated.
In human breast milk concentration of clonidine are approximately twice those in 
maternal plasma. So it is not recommended.
USE IN PAEDIATRICS:
1-2 µg/kg body weight of clonidine is administered along with local anaesthetics in 
caudal epidural analgesia to prolong the duration of analgesia.
USES: 19
- As an anxiolytic/sedative
- Treatment of hypepertensive crisis.
- To prolong the duration of analgesia
(Intrathecally/epidural/peripheral nerve blocks/ Intraarticular)
- To prevent/treat shivering 
- For withdrawal from addictive drugs (Narcotics, alcohol or smoking).
- Chronic pain syndromes
- In diabetic diarrhea due to autonomic neuropathy
- Reduce menopausal hot flushes.
CONTRAINDICATIONS:
- Hypersensitivity to clonidine
- Brady arrhythmia or AV block patients
- Severe Cardiovascular diseases
- In patients with Cardiovascular/haemodynamic instability
- Pregnant/Lactating women
- Anticoagulant therapy/Bleeding diathesis
 ADVERSE EFFECTS: 20
- Hypotension may occur and usually responds to intravenous fluids, if 
necessary parenteral ephedrine.
- Bradycardia may occur and responds to atropine.
- Sedation which is a desirable effect.
- Mental depression, disturbed sleep.
- Dryness of mouth, nose, eyes.
- Constipation
- Confusion, headache, hyperaesthesia.
- Skin reactions (rash, urticaria and pruritus)
OVERDOSAGE:
No specific antidote for Clonidine overdosage
- Mainly supportive care
- For brady cardia Inj.Atropine will increase heart rate.
- For fall in blood pressure. Intravenous fluids and ephedrine
- An overdosage can produce Vasospasm and hypertension. For 
hypertensive emergency IV furosemide, diazoxide or α-blocking agents may be 
used.
Hypertension may develop early and may be followed by hypotension, bradycardia, 
hypothermia, drowsiness, irritability and miosis can occur.
STRUCTURE OF EPINEPHRINE
S
PHARMACOLOGY OF EPINEPHRINE: 24
Adrenaline is an endogenous catecholamine secreted in the adrenal medulla. This is 
synthesised from the amino acid phenylalanine. Tyrosine hydroxylase is the rate limiting 
enzyme and its inhibition results in depletion of endogenous. catecholamines .
 Adrenaline is a direct sympathomimetic drug which act directly as agonist on α 
and β receptors.
Adrenaline : α
1
+α
2
+β
1
+β
2
 and weak β
3
 action
Noradrenaline : α
1
+α
2
+β
1
+β
3
 but no β
2 
action
Isoprenaline : β
1
+β
2
+β
3 
but no α action
LOCATION OF α RECEPTORS:
α1 - Post Junctional on effector organ
α2 - Pre junctional on nerve ending (α2A) Also post 
junctional in brain, pancreatic beta cells platelets and extra 
junctional in certain blood vessels
LOCATION OF β RECEPTORS
 β1 β2 β3
Heart Bronchi, blood vessels Adipose tissue
JG cells in Kidney  Uterus, GI tract, Urinary tract, eye
 PHARMACOLOGICAL ACTIONS
HEART:
Adrenaline increases HR by increasing the slope of slow diastolic depolarization of 
cells in the SA node. It also activates latent pacemakers in AV nodes and Purkinjie 
fibres. Arrhythmias can occur by action on α1 receptors at high doses. Refractory period 
of all types of cardiac cells is reduced.Cardiac Stimulations (β
1
) increase rate, force and 
conduction velocity.
BLOOD VESSELS:
Constriction of arterioles and veins to rise in BP (mainly α
1
).Dilatation of arterioles 
and veins fall in BP by β
2 
action
RESPIRATORY SYSTEM:
Adrenaline is a potent bronchodilator (β
2
).
EYE:
Mydriasis occurs due to contraction of radial muscles of iris (α
1
) Intraocular 
pressure decreases.
GIT:
GIT relaxation occurs through activation of both α and β receptors. Peristalsis is 
reduced.
BLADDER:
Detrusor is relaxed (β) and trigone is constricted (α) hinders micturition. Renin 
release from kidney (β
1
)
PERIPHERAL NERVES:
      It increases the neuronal uptake of local anasthetics by decreasing the systemic 
absorption by its vasoconstrictive action. 
UTERUS:
In Non pregnant uterus contraction (α) occurs. In term pregnant women relaxation 
occurs (β)
SKELETAL MUSCLE:
Neuromuscular transmission is facilitated. α receptor activation augments Ach 
release (α
1
). Tremor occurs due to β
2
 activation.
CNS: 
Poorly penetrates blood brain barrier but restlessness, apprehension and tremor may 
occur.
METABOLIC:
Glycogenolysis,Hyperglycemia,hyperlactacidemia(β).lipolysis, Calorigenesis 
(β
1
+β
2
), Reduction of Insulin (α
2
) and augmentation of glucagon (β
2
) secretion.
PHYSICAL CHARACTERISTICS: 25
   1 Amp: 1 ml (1:1000)
   Adrenaline: 1.0 mg
METABOLISM:
Epinephrine is rapidly inactivated by the enzyme Catechol-O-Methyl transferase 
(COMT).
Epinephrine  →    Metaneohrine  →Conjugated Metanephrine
MAO MAO MAO
3.4. dihydroxy        3 methoxy, 4 Hydroxy      3 Methoxy, 4 hydroxy 
Mandelic Acid Mandelic acid (VMA) Phenylglycol
Oxidative deamination by MAO also plays a part. 3methoxy4hydroxymandelic acid and 
metanephrine are mostly conjugated with glucuronic acid or sulfate before excretion in 
the urine.
PREPARATIONS AVAILABLE:
IV, IM or Sc 1 mg in 1 ml (1:1000)
0.5% by aerosol
DOSAGE: 26 In local infiltration and nerve block 1 : 2,00,000 to 1:4,00,000
IV INFUSION:
β2 1-2 µg/min. 0.02 mg/kg for Caridac collapse
β1 & β2 2-10 µg/min.
Epinephrine 1% for bronchospasm
α1 > 10 µg/min. (1g/100 ml)
USES:24
- Cardiac arrest
- Anaphylactic Shock
- Severe hypotension/sepsis induced hypotension
- Severe bronchial asthma
- Hay fever
ADVERSE EFFECTS: 24
Transient restlessness, Palpitation, anxiety, tremor, pallor may occur after s.c or 
i.m. injection of adrenaline. Marked rise in BP, leading to cerebral haemorrhage, 
Ventricular tachycardia /fibrillation are due to large doses or inadvertent i.v injection.
CONTRADICTIONS: 24
- Hypertensive Patients
- Hyperthyroidism
- In Angina Patients/severe heart diseases
- Not used along with local anaesthetics for regional blocks in 
finger, lips, toes.
- Along with halothane in general anaesthesia.
- Patients receiving β blockers.
REVIEW OF LITERATURE
Regional anaesthetic techniques are widely used for the provision of excellent 
intraoperative and post operative analgesia. Relief of post operative pain following 
surgery on the upper extremities can be achieved by commonly used analgesics, 
systemic opioids and brachial plexus block. The problem with local anaesthetic alone is 
that they do not provide prolonged postoperative analgesia.
Several adjuvants have been tried along with local anaesthetics to prolong the 
duration of post operative analgesia without the problems of prolonged motor blockade 
or systemic side effects.
Several studies using α
2
-adrenergic agonists with bupivacaine in peripheral nerve 
blocks were conducted for prolongation of post operative analgesia. Initial hypothesis 
proposed for the mechanism of action were as follows: 34
1. Based on the knowledge that the primary action of the α-adrenergic agonists is on 
the α
2
-adrenoreceptors located on the afferent terminals of the peripheral neurons 
and neurons in the superficial laminae of the spinal cord and within several 
brainstem nuclei implicated in analgesia. It stimulates inhibitory α
2
-adrenoreceptors 
to reduce neural transmission. It acts by inhibiting voltage gated Na+ and K+ 
channels and suppresses the generation of action potentials.
2. A second hypothesis may be through the release of acetylcholine. This inhibits the 
release of substance P in the neuraxial region. Currently 
there is significant cytochemical and behavioural evidence for the existence of α
2
-
adrenoreceptors.
The demonstration of α
2
-adrenoreceptors in the peripheral nervous system 
prompted recent investigations on the use of Clonidine with local anaesthetics for 
regional anaesthesia procedures like brachial plexus block. Lipid solubility and the 
affinity of α-adrenergic agonists to their receptors seem to be important factors in 
determining the duration of action.
Several studies have shown that the addition of the α-adrenergic agonists to 
bupivacaine produces a longer period of post operative analgesia than the local 
anaesthetics alone.
SUBCLAVIAN PERIVASCULAR TECHNIQUE FOR BRACHIAL PLEXUS 
BLOCK:
1. Franco CD, Vieira ZE (2000) did a study on Subclavian Perivascular Block and 
its success using a nerve stimulator. They concluded that the Subclavian 
perivascular technique consistently provides an effective block for surgery on the 
upper extremity. At the site of injection the plexus is reduced to its smallest 
components and the sheath is reduced to its smallest volume which explains in 
greater part the success obtained with this block. 27
2. Brown DL (1993) did a study on brachial plexus anaesthesia and analysed the 
various sites at which the plexus can be blocked. They studied the supraclavicular, 
interscalene, infraclavicular and axillary approaches. They concluded that the 
supraclavicular block produces 
anaesthesia of the entire upper extremity in the most consistent and efficient manner 
than any other brachial plexus block technique. 28
3. Lanz.E, Theiss D, Jankovic D (1983) studied the extent of blockade using various 
techniques of brachial plexus blocks. The extent of sensory and motor blockade 
was assessed using 0.5% bupivacaine. They concluded that the subclavian 
Perivascular approach of Winnie resulted in a homogenous blockade of the nerves 
of the brachial plexus.29
4. Winnie and Ramamoorthy (1977) postulated that the trunk of brachial plexus are 
arranged so that the central fibres  are longest supplying the extremities of the limb, 
while the shorter fibres are arranged more peripherally as their area of supply is 
more proximal.
Winnie groups the fibres into two: the Peripheral Mantle bundle which contains the 
outer motor and inner sensory fibres corresponding to all the early branches of the 
brachial plexus being motor: and a central core bundle with the outer motor fibres 
supplying muscles of the forearm and the inner sensory fibres carry sensation from 
the hand.
THUS THE ORDER OF BLOCKADE IS AS FOLLOWS:
Loss of motor power to the shoulder and upper arm; loss of sensation in the upper 
arm; loss of motor power of the forearm; and loss of sensation of the hand. 30
5. Lanz.E, Theiss (1979) compared the supraclavicular and the interscalene approach 
of brachial plexus block. They concluded that with the Supraclavicular block, 
motor as well as sensory blockade of all 
the nerves of the brachial plexus occurred with about the same frequency. Following 
both the techniques, blockade developed from the proximal to distal with motor 
blockade preceding the sensory block.31
6.   Cheryl etal32 did a comparative study with 0.25% bupivacaine and 0.25% 
ropivacaine in the brachial plexus. They concluded that both groups required 
supplementation with peripheral nerve blocks or general anaestheia in a large 
number of cases. In view of the frequent need for supplementation with both 0.25% 
bupivacaine and 0.25% ropivacaine they do not recommend using the 0.25% 
concentrations of these local anaesthetics to provide brachial plexus block.
CLONIDINE IN BRACHIAL PLEXUS BLOCK WITH LOCAL 
ANAESTHETICS:
1. Erlacher W et al (2001) evaluated the efficacy of adding clonidine to mepivacaine, 
Ropivacaine and bupivacaine in axillary perivascular brachial plexus blcok by 
comparing 3 groups. They concluded that the onset of sensory block with 
mepivacaine is faster than Ropivacaine and bupivacaine but the duration of motor 
blockade and sensory blockade was prolonged by Clonidine in the mepivacaine and 
bupivacaine groups.33
2. Castia A.et al conducted a double blind study for improving postoperative 
analgesia after axillary brachial plexus anaesthesia with 0.75% ropivacaine with 1 
µg/kg of Clonidine in two groups, each with 15 patients. By adding 1 µg/kg of 
Clonidine to 20 ml of ropivacaine 0.75% for axillary brachial plexus anaesthesia, a 
3 hour delay in first 
analgesic request postoperatively without clinically relevant effects on the degree of 
sedation and cardiovascular homeostasis was observed.34
3. Salvatore sia and Antonella Lepri (1999) conducted a double blinded study to 
determine whether Clonidine has analgesic effects when administered into the 
brachial plexus sheath. They concluded that Clonidine prolongs the analgesic 
effects of brachial plexus block when mixed with local anaesthetic bupivacaine. 
Anesth analog 1999:88:1109-1112.35
4. E1 Saied AH et a1 conducted a randomised double blinded placebo controlled 
study using Clonidine 150 µg in 40 ml of 0.75% Ropivacaine. Control group 
received 1 ml NS to the 0.75% Ropivacaine. The results showed an increase in 
duration of sensory and motor block and duration of analgesia without an increased 
incidence of side effects in the clonidine group compared to the control group. 36
5. Hutschala et al in 2004 conducted the study by adding Clonidine to local 
anaesthetics bupivacaine 0.25%. They found that addition of Clonidine to local 
anaesthetics enhances pain relief after peripheral nerve block. Lower clonidine 
plasma concentration after peripheral nerve blockade strongly suggest a local 
effect. Administration of Clonidine was associated with sedation and a decrease in 
heart rate and blood pressure independent of the route of administration. 37
6. Duma et al in 2005 conducted a randomised controlled study in axillary brachial 
plexus block. Using Clonidine as an adjuvant to local anaesthetic four groups of 20 
patients in each group were investigated 
using i) 40 ml of 0.5% levobupivacaine plus 150 µg of Clonidine ii) 40 ml of 
levobupivacaine 0.5% plus 1 ml of 0.9% Nacl iii) 40 ml of bupivacaine 0.5% plus 
150 µg clonidine. iv) 40ml of bupivacaine 0.5% plus 1 ml of NaCl 0.9% 
respectively. The onset of motor and sensory block and duration of sensory block 
were recorded. They found that there is no significant difference between groups 
but a significantly higher variance (P<0.001) was found in the two groups with 
Clonidine than in the two groups without. These finding suggest responder and 
nonresponder behaviour is a result of the addition of clonidine. 38
7. Adnan T et al (2005) conducted a double blind controlled study on 28 adult 
chronic renal failure patients. The control group received 40 ml of lignocaine 1% 
combined with 1 ml of NS and the clonidine group received 40 ml of lignocaine 
1% with 150 µg of Clonidine. They concluded that onset time for sensory 
blockade was longer in the Clonidine group than in the controls (P=0.013) and 
both motor and sensory blocks lasted longer in the Clonidine group (P=0.004, 
P<0.001, respectively). In addition, the Clonidine group had lower mean arterial 
pressures, heart rates and higher sedation scores compared to the control (P<0.05 
for all).39
CLONIDINE IN OTHER REGIONAL ANAESTHETIC PROCEDURES
1. Filos KS et al in 1994 evaluate the dose response 
haemodynamic and analysis profiles of intrathecal 
clonidine in a randomized prospective study. The study 
concluded that there is a dose dependent analysis after 
intrathecal clonidine. At 300 and 450 micro gram 
intrathecal clonidine a relative haemodynamic stability 
is observed 40
2.
2
3. Filos KS et al, Conducted a double blind placebo controlled 
study to evaluate the efficacy of intrathecal clonidine on 
pain following LSCS under general anaesthesia. The 
results suggest that intrathecal clonidine 150 micro 
grams is effective in controlling pain following 
caesarean section but may cause side effects such as 
hypotension, sedation and dryness of mouth 41 
4. Huang Y et al, done a randomised dose ranging study in eighty 
ASAI-III patients to determine the optimal epidural 
dose of clonidine to provide the best analgesia with 
fewest side effects. He concluded that the groups 
receiving clonidine experienced less post operative pain 
(P= 0. 002) 42
5. Upadhyay P and Handa H studied the duration of analgesic 
action and incidence of side effects of clonidine added 
to bupivacaine given caudally in a 50 paediatric 
patients. They concluded that the addition of clonidine 
in the dose of 1 micro gram/Kg to bupivacaine (0.25%) 
0.75 ml/kg for caudal blockade significantly prolongs 
the duration of analgesia without any side effects. 43
6. Gentili M et al, done a prospective comparative study in a 
group of 40 patients to assess the potential analgesic 
effect of clonidine after intra articular administration. 
They concluded that low dose of intra articular 
clonidine produces analgesia unrelated to vascular 
uptake of the drug. 44 
MATERIALS AND METHODS
   This study was carried out in the plastic and orthopaedic surgery theatre, Government 
General Hospital, Chennai after obtaining institutional approval. The aim of the study 
was to evaluate the efficacy of blocking the brachial plexus with bupivacaine and the 
effects of added alpha adrenergic agonists like clonidine and epinephrine.
STUDY DESIGN:
A prospective, randomised study conducted on 40 ASA I and II   patients undergoing 
upper limb surgeries under supraclavicular brachial plexus block who fulfil inclusion 
criteria
The study was started after receiving institutional ethical committee approval and 
informed written consent from all the patients and they were randomly divided into two 
groups.
TWO GROUPS:
BA -30ml of 0.375% bupivacaine with 5 µg/ml of epinephrine. 
BC -30ml 0f 0.375% bupivacaine with 1 µg/kg of clonidine.
Inclusion criteria: 
The following criteria were taken for including the patients in this study.
• ASA  Status  I and II 
• Age between 18 and 65 years 
• Weight  >50 kg
• Patients undergoing surgery of upper limb with possibility of shoulder abduction 
for assessment of motor blockade.
Exclusion criteria:
• Patient refusal 
• Known allergy for the drugs to be studied.
• Local infections / Sepsis 
• Coagulation abnormalities 
• H/o significant  neurological, psychiatric , neuromuscular, cardiovascular, 
pulmonary, renal or hepatic disease 
• Alcohol/drug abuse 
• Pregnancy/lactating women 
• Chronic  analgesic therapy (other than NSAIDS) 
• On adrenergic drugs 
• Peripheral neuropathy 
• Not  fulfilling inclusion criteria
MATERIALS:
1. Sterile tray for regional blocks 
2. Drugs for the block
                0.5% bupivacaine
                Inj.Clonidine
                Inj.Epinephrine
                Normal saline
3.
3
4. Nerve stimulator with insulated needle
5. Equipments and drugs for resuscitation
6. Equipments and drugs for conversion to general anaesthesia in the case of block 
failure
METHODS:
PRE OPERATIVE PREPARATION:
Patients were pre-operatively assessed and the procedure was explained to the patient. 
Written informed consent was obtained. They were assessed with particular attention to 
any contraindications.
         Assessment of pain using Visual Analogue Scale (VAS) post operatively was 
explained to the patient pre operatively.
PRE MEDICATION:
Tab.ranitidine 150mg 2 hours before surgery with sips of water.          
CONDUCT OF ANAESTHESIA:
On arrival of the patient in the operating room, monitors like pulse oxymeter, non 
invasive blood pressure and ECG were connected and baseline values were recorded. An 
intravenous access was obtained in the opposite arm. 
SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK BY THE SUBCLAVIAN 
PERIVASCULAR TECHNIQUE7
Patients were positioned supine with the head turned away from the side to be blocked 
and the ipsilateral arm adducted. The neck was prepared with povidone iodine solution 
and draped with sterile towels.
LANDMARKS:
  The essential landmarks to be identified are 
1. Cricoid cartilage
2. Interscalene groove
3. Clavicle midpoint
4. Subclavian artery
PROCEDURE: FIG - 6
A line was drawn laterally from the cricoid cartilage to cross the sternomastoid at its 
midpoint. The interscalene groove was located behind the midpoint of the posterior 
border of the muscle. To confirm this position the middle and anterior and middle 
scalene muscles were made prominent by asking the patient to inspire vigorously or 
sniff. The interscalene groove was then followed distally towards the clavicle. 
Approximately 1 to 1.5 cm above the midpoint of the clavicle, the pulsation of the 
subclavian artery was made out in the interscalene groove.  
Under strict aseptic precautions standing by the side of the patient, the interscalene 
groove was palpated with the index finger, reversing the hands for the opposite side. 
Patient placed supine with head turned away from the side to be blocked and ipsilateral 
arm adducted, the interscalene groove and the midpoint of clavicle identified. After local 
infiltrations of 1 ml of 2% lignocaine intradermally in the interscalene groove 1 to 1.5 
cm above the clavicle, a 22G, 50 mm short bevelled unipolar insulated needle connected 
 
to a nerve locator is directed caudally towards the ipsilateral nipple and posteriorly. End 
point in a nerve stimulator is a motor response with an output lower than 0.5mA. to 
avoid intra vascular injection aspiration done every 3-5 ml of study drug injected.
EVALUATION OF THE BLOCK:
   The following observations were made. 
• Vital signs monitoring; heart rate, non invasive blood pressure, oxygen saturation 
and sedation score were measured every minute for the first 5minutes and every 5 
minutes thereafter until the end of surgery. For statistical purposes, they were 
documented at 0, 1, 2, 5, 10, 15, 30 minutes and every 30 minutes thereafter.
• Immediately following the administration of the drug, patients were evaluated for 
the onset of sensory and motor blockade every minute.
•  Sensory block evaluated by temperature sensation using ether soaked cotton in 
the skin dermatomes C4-T2.
• Onset of motor blockade was assessed by loss of shoulder abduction. Only 
patients with complete motor block are included in the study. Failure of the block 
to be established even after 20 minutes was taken as block failure.
• Analgesic failure were managed with local anaesthetic supplementation or 
General anaesthesia as appropriate .Those patients are excluded from the study.
• After confirmation that the block has taken up, surgery was started. 
•
•
• Patient receiving supplemental O2 and intravenous fluids throughout the 
procedure
• Sedation is assessed using Ramsay sedation score (6 points). If the patient is 
anxious even 1 hour after blocking the plexus, inj.Midazolam was given to 
achieve a sedation score of 2 to 3.
• Local anaesthetic toxic reactions including subjective and objective 
manifestations like circumoral numbness, tinnitus, twitching, convulsions, etc., 
were looked for and appropriate measures were taken.
• Complications associated with the technique like intravascular injection, 
intrathecal or epidural injection and pneumothorax were looked for and 
appropriate measures were taken to meet any such eventuality. 
• Postoperatively heart rate, non invasive blood pressure, oxygen saturation and 
sedation scores are recorded at 0 min, 30 min, 60 minutes, 2 hr, 4 hr, 6 hr, 12 hr 
and 24 hr.
• Duration of sensory block (time elapsed between injection of the drug and 
appearance of pain in the surgical site).
• Duration of sensory blockade was tested postoperatively using the VAS score 
every ½ hour for the first six hours thereafter every 2 hours till 24 hours. VAS 
scale (0-10points), where 0 represents no pain and 10 means worst possible pain.
• Pentazocine 30 mg intramuscularly is given as a rescue analgesic when the pain 
score is more than 4.
s
SIDE EFFECTS LOOKED FOR 24 HOURS:
a. Bradycardia; heart rate less than 60 beats per minute.
b. Hypotension; more than 30% decrease from baseline 
value.
c. Sedation
d. Shivering
e. Dry mouth
f. Arrhythmias 
g. Local anaesthetic toxicity
All the data were subjected to statistical analysis. The parameters of age and sex were 
analysed using Chi-square test. Onset time for motor and sensory blockade, duration of 
surgery and duration of sensory blockade were analysed with LEVENE’s Test and t-test 
and the statistical significance estimated. A P value less than equal to 0.05 was 
considered statistically significant.
OBSERVATIONS AND RESULTS
The patients included in this study were divided into two groups consisting of 20 
patients each. 
Group BC (n=20) received 30ml of 0.375% bupivacaine with 
1 micro gram/kg of clonidine.
Group BA (n=20) received 30ml of 0.375% bupivacaine with 
5 micro gram/ml of epinephrine.
AGE
MEAN AGE IN YEARS IN THE TWO GROUPS STUDIED
Group N Mean(years) Median S.D
BA 20 32.50 27.50 12.89
BC 20 32.05 28.00 11.26
STATISTICAL ANALYSIS OF AGE DISTRIBUTION
df F p Value
Chi-Square test 38 0.275 0.541
GE RANGE GROUP CROSS TABULATION
Age Range
Group total
BA BC
< 30 years Count 11 12 23
% With in age range 47.8% 52.2% 100.0%
30-40 years Count 5 4 9
% With in age range 55.6% 44.4% 100.0%
40-50 years Count 1 3 4
% With in age range 25.0% 75.0% 100.0%
50-60 years Count 3 1 4
% With in age range 75.0% 25.0% 100.0%
Total Count 20 20 40
% With in age range 50.0% 50.0% 100.0%
Thus as the two groups were similar with respect to age distribution the difference was 
not statistically significant.
WEIGHT
MEAN WEIGHT IN KGS IN THE TWO GROUPS STUDIED
N Mean (Kgs) SD
Group BA 20 60.90 7.84
Group BC 20 64.30 8.29
STATISTICAL ANALYSIS OF WEIGHT DISTRIBUTION
Levene’s test t test for equality of means
F Siqnificant t df p Value
.612 .439 -1.333 38 .191
There was no statistically significant difference among the two groups with respect to 
weight distribution.
SEX
SEX DISTRIBUTION IN THE TWO GROUPS STUDIED
Value df p Value
Chi-square 0.784 1 0.376
There was no statistically significant difference among the two groups as regards sex 
distribution.
d
TYPE OF SURGICAL PROCEDURE
Procedures Group BA Group BC
ORIF 12 9
Posttraumatic Deformity 4 2
correction
EF 1 4
Radial head excision 1 2
Sequestrectomy & IF 1 1
Implant exit 1 1
Tension band wiring 1 1
ORIF - Open Reduction and Internal Fixation
IL - Interlocking
EF - External Fixation
AE - Above Elbow
The two groups were well matched for the type of surgical procedure suggesting 
postoperative pain of similar intensity.
p
     
 
Duration of surgery in minutes 
mean duration of surgery in the two groups
Group N Mean (minutes) SD
BA 20 102.75 22.56
BC 20 109.00 21.74
STATISTICAL ANALYSIS OF DURATION OF SURGERY
Levene’s test t test for equality of means
F Significant t df p Value
.000 .985 -.892 38 .378
The duration of surgery in the groups was not statistically significant.
ONSET OF SENSORY BLOCKADE IN MINUTES
MEAN ONSET OF SENSORY BLOCK IN THE TWO GROUPS
Group N Mean(minutes) SD
BA 20 6.25 1.33
BC 20 5.85 1.27
STATISTICAL ANALYSIS OF ONSET OF SENSORY BLOCKADE
Levene’s test t test for equality of means
F Significant t df p Value
.156 .695 .972 38 .337
Onset of sensory blockade in the two groups was comparable and there was no 
statistically significant difference among the two groups.
Onset of motor blockade in minutes
MEAN ONSET OF MOTOR BLOCK IN THE TWO GROUPS
Group N Mean(minutes) SD
BA 20 3.80 .834
BC 20 3.55 1.05
STATISTICAL ANALYSIS OF ONSET OF MOTOR BLOCKADE
Levene’s test t test for equality of means
F Significant t df p Value
1.428 .240 .834 38 .410
The two groups did not show any statistical significance with respect to the time for 
onset of motor blockade.
DURATION OF SENSORY BLOCKADE IN HOURS
MEAN DURATION OF SENSORY BLOCKADE
Group N Mean(Hours) SD
BA 20 7.12 .63
BC 20 12.69 1.28
STATISTICAL ANALYSIS OF DURATION OF 
SENSORY BLOCKADE
Levene’s test t test for equality of means
F Significant t df p Value
9.786 .003 -17.398 38 .001
.
Intra Operative Pulse Rate
Intra Operative Systolic BP Trend
ntra Operative Diastolic BP Trend
Post Operative Pulse Trend
Post Operative Systolic Bp Trend
Post Operative Diastolic Bp Trend
Patients in group BC had a longer duration of sensory blockade than patients in group 
BA and the difference was statistically significant.
HEMODYNAMIC PARAMETERS
There was no significant difference in the vital signs like heart rate, systolic blood 
pressure, diastolic blood pressure and saturation (SPO2) from the baseline throughout the 
surgery and the post operative period of 24 hours in the two groups.
SIDE EFFECTS
None of the patients in the two groups developed any of the side effects like 
bradycardia, hypotension, sedation, dry mouth, dizziness, arrhythmias and local 
anaesthetic toxicity.
DISCUSSION
The subclavian perivascular approach to the brachial plexus with the guidance of nerve 
locator has gained popularity because of satisfactory anaesthesia and a decreased failure 
rate with this approach. 
Franco CD Vieira ZE 27 in their study on subclavian perivascular brachial plexus block 
found that the subclavian perivascular block provides an effective block for surgery on 
the upper extremity. Brown28 in his study on analysis of options in brachial plexus 
anaesthesia concluded that the supraclavicular block provides anaesthesia of the entire 
upper extremity in the most consistent and time efficient manner compared to other 
techniques. Lanz29 and his colleagues in their study on the extent of blockade following 
various techniques of brachial plexus block demonstrated that the subclavian 
perivascular approach to the brachial plexus resulted in a homogenous blockade of the 
nerves of the brachial plexus.
With the supraclavicular approach injection is made at the level of the trunks. As there 
are only three components at this level, failure rates should be extremely low. With the 
supraclavicular technique incidence of pneumothorax is 0.5-6% which is usually 
asymptomatic.
Therefore in this study the subclavian perivascular approach to the brachial plexus was 
used.
Cherryl et al 32 in their comparative study of 0.25% bupivacaine and 0.25% ropivacaine 
for brachial plexus block demonstrated a higher incidence of supplementation required. 
Therefore they recommended using 
local anaesthetics of concentration more than 0.25% to provide brachial plexus block. 
Therefore, in this study 0.375% bupivacaine is used.
According to Denise J.Wedel in the subclavian perivascular technique the solution is 
delivered at a point in which the trunks are compactly arranged. So a volume of 20-30ml 
of local anaesthetic solution is sufficient. Therefore in this study a volume of 30ml was 
used.
The demonstration of  α2 receptors in the peripheral nervous system prompted recent 
investigations on the use of  α2 receptor agonists either alone or combined with local 
anaesthetics for regional anaesthesia procedures like brachial plexus block. Several 
studies have shown that the addition of  α2 agonist clonidine with bupivacaine produces 
a longer duration of post operative analgesia.
In this study, the alpha agonists like clonidine or adrenaline were added as an adjuvant 
to bupivacaine in brachial plexus block and their effects were evaluated. In the study by 
Jean J. Eledjam MD and his colleagues46 the mean weight of patients was 64.03 ± 2.2kg 
in clonidine with bupivacaine group and 66.3 ± 2kg in adrenaline with bupivacaine 
group.
In this study, the mean weight of patient in group BC was 64.30 ± 8.29kg and in group 
BA was 60.90 ± 7.84kg
DOSAGE OF ALPHA AGONISTS
In the study by Castia et al34 adding 1 micro gram/kg of clonidine to local anaesthetics 
for brachial plexus block provided a prolonged duration of sensory analgesia 
postoperatively without clinically relevant effects on 
the degree of sedation and cardiovascular homeostasis. Therefore in this study clonidine 
was used on a weight basis 1 micro gram/kg.
In the study by Eledjam JJ et al46 adrenaline 150 micro gram was added to 30 ml of 
bupivacaine (i.e 5µg/ml) to find the efficacy of alpha agonist on the brachial plexus 
block. So in our study adrenaline 5µg/ml was added to local anaesthetic and compared 
with α2 receptor agonist clonidine.
ONSET OF SENSORY BLOCKADE
The onset of sensory analgesia was tested by temperature testing using ether soaked 
cotton in the skin dermatome C4-T2. In this study the time for onset of sensory analgesia 
was 6.25 ± 1.33 minutes in group BA and 5.85 ± 1.26 minutes in group BC. The 
difference was not statistically significant among the two groups. In the study by 
Eledjam and his colleagues46 there was no difference in onset time of sensory blockade 
between clonidine and adrenaline group.
ONSET OF MOTOR BLOCKADE
The onset of motor blockade was tested by loss of shoulder abduction. In this study the 
onset time for motor blockade was 3.80 ± 0.834 minutes in group BA and 3.55 ± 1.05 
minutes in group BC. The difference was statistically insignificant among the two 
groups. The finding that motor blockade develops before sensory blockade is consistent 
with the study by Winnie and Ramamoorthy30. In the study by Eledjam and his 
colleagues46 there was no difference in the onset of motor blockade between the two 
group’s clonidine with bupivacaine and adrenaline with bupivacaine. In another study by 
EL Saied AH36 and colleagues there was no difference in onset time of motor block 
between the clonidine groups and control groups. 
b
DURATION OF ANALGESIA
In our study the duration of sensory block in group BA was found to be 7.12 ± 0.63 
hours and for group BC 12.69 ± 1.28 hours. Thus the addition of clonidine to 
bupivacaine prolongs the duration of analgesia significantly than the bupivacaine with 
adrenaline group.
In the study by Eledjam JJ46 and colleagues the addition of 150 µg clonidine with 0.5% 
bupivacaine conferred a mean duration of postoperative analgesia of 994.2 ± 34.2 
minutes compared with 728.3 ± 35.8 minutes for 150µg of adrenaline with 0.5% 
bupivacaine.
In the study by Casati A et al34 the addition of clonidine provided 15.2 hours of 
postoperative analgesia. In the other study by EL Saied AH et al36 the addition of 
clonidine showed a duration of sensory analgesia from 587 minutes to 828 minutes.
In the study by Erlacher et al33 the addition of 150µg of clodinine to 40ml of 0.5% 
bupivacaine prolonged  the duration of sensory blockade to 972±72 minutes.
In the other study by Adnan T and colleagues47 the addition of clonidine to local 
anaesthetics prolongs the duration of sensory block significantly with the P value < 
0.001.
In the study by Duma A and colleagues, findings suggest higher variance in the duration 
of sensory block within the clonidine group. They concluded the study by saying there is 
a responder and non responder behaviour within the patients in the clonidine group.
 
HAEMODYNAMIC PARAMETERS
In this study there was no significant change in the haemodynamic parameters from the 
baseline in both the groups.This was consistent with the observation by EL Saied AH et 
al36. Eledjam JJ et al46 and Casati A et al34.
In the study of 28 adult chronic renal failure patients by Adnan T et al 47 addition of 
clonidine in brachial plexus block decreases both heart rate and blood pressure.
SIDE EFFECTS
None of the patients in the two groups showed any of the side effects like bradycardia, 
hypotension, sedation, dry mouth, dizziness, arrhythmias and local anaesthetic toxicity.
In the study by Eledjam JJ and Colleagues 46 in 1991 none of the patients reported 
clonidine related side effects. In another study performed by Casati A in 2001 34, no 
significant clonidine related side effects like sedation or haemodynamic instability when 
added to the local anaesthetic was observed. This was consistent with the observation by 
EL Saied AH and colleagues 36.
But in the study of 28 adult chronic renal failure patients by Adnan T et al 47 in 2005 
showed that the clonidine group had lower mean arterial pressure, heart rate and higher 
sedation score compared to the control groups.
 
SUMMARY
On comparing the effects of added alpha adrenergic agonists clonidine and epinephrine 
to bupivacaine for supraclavicular brachial plexus block, it was found that
• Onset of sensory blockade was similar in the two groups.
• Onset of motor blockade was similar in the two groups.
• Duration of sensory blockade was significantly longer in the clonidine with 
bupivacaine group compared with the epinephrine with bupivacaine 
group.
• There was no significant difference in the haemodynamic parameters between 
the two groups.
• No clonidine or epinephrine related side effects were recorded in the groups.
• No other complications were seen in the two groups.
N
CONCLUSION
From this study it can be inferred that the addition of clonidine to 0.375% bupivacaine 
prolonged the duration of analgesia significantly when compared to epinephrine added 
to 0.375% bupivacaine.
In conclusion the addition of 1µg/Kg of clonidine to 0.375% bupivacaine in 
supraclavicular brachial plexus block provides a significant advantage over 5µg/ml of 
epinephrine to 0.375% bupivacaine in terms of postoperative analgesia without any 
significant side effects.                                     
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PATIENT PROFORMA
Name:                   Informed written Consent:
Age:          Diagnosis:
Sex: Surgery:
ASA: Weight:
MPC: Comorbid Conditions:
INVESTIGATIONS:  
 Hb BT CT
MONITORS:
               HR                  NIBP                     Sa02
GROUPS:
        BC
        BA
 
BLOCK CHARACTERISTICS:
Time of Injection Time of onset Time Elapsed
Sensory Block
Motor Block
INTRAOPERATIVE HAEMODYNAMICS:
Time
HR
BP
Sa02
Sedation Score
0 Min
1 Min
2 Min
3 Min
4 Min
5 Min
10 Min
15 Min
20 Min
25 Min
30 MIn
35 Min
40 Min
45 Min
4
50 Min
55 Min
60 Min
POSTOPERATIVE HAEMODYNAMICS:
Time HR BP Sa02 Pain Score Sedation Score
0 Min
15 Min
30 Min
1 Hr
2 Hr
3 Hr
4 Hr
6 Hr
12 Hr
24 Hr
Time of first appearance of pain at surgical site Total Duration Of sensory Block
PERIOPERATIVE COMPLICATIONS:
Intra Operative Post Operative Treatment Given
Local Toxicity
Bradycardia
Hypotension
Shivering
Dry Mouth
Arrhythmias
Headache
Dizziness
D
Bupivacaine with Epinephrine - group BA
S.No Age weight in kg sex
duration 
of 
surgery 
in 
minutes 
onset of 
sensory 
block in 
minutes
onset of 
motor 
block in 
minutes
duration 
of 
sensory 
block in 
hours
1 60 50 F 140 6 4 7.15
2 19 55 F 70 4 3 6.4
3 32 70 M 100 7 4 7.45
4 18 55 M 100 6 4 7.2
5 23 63 M 80 5 3 6.4
6 26 55 M 90 4 3 7
7 38 60 M 80 6 2 7.53
8 23 55 M 95 5 3 7.4
9 40 80 M 120 7 4 7.1
10 31 60 M 130 8 4 8.15
11 45 50 F 150 7 5 7.3
12 25 60 M 90 8 5 6.3
13 38 65 M 90 6 4 8.4
14 27 60 M 80 9 5 8.1
15 56 70 M 110 7 4 7.2
16 28 60 F 90 5 3 6.45
17 20 55 M 100 7 4 7.3
18 21 60 M 110 6 3 6.1
19 55 60 M 140 5 4 6.45
20 25 75 M 90 7 5 7.1
 
Bupivacaine with clonidine - group BC
S.No
Age
weight in kg
sex
duration of surgery in minutes 
onset of sensory block in minutes
onset of motor block in minutes
duration of sensory block in hours
1
45
75
M
130
5
3
13.15
2
40
60
M
100
4
2
12.25
3
50
78
M
140
5
3
14.3
4
25
60
M
140
6
3
15.45
5
28
70
M
80
3
2
12.1
6
28
75
M
120
5
3
11.3
7
38
75
M
90
6
4
14
8
20
60
M
60
8
6
11.15
9
18
54
M
100
5
4
12.45
10
55
60
M
140
6
3
11.3
11
20
55
M
120
5
3
12.15
12
29
60
M
90
7
5
13.3
13
20
64
M
100
7
4
14.1
14
28
65
M
90
6
4
11.3
15
25
50
M
120
5
3
10.45
16
50
60
F
130
7
5
12.3
17
28
55
F
100
6
3
13.2
18
22
65
M
110
7
3
14.1
19
32
70
M
100
8
5
13.15
20
40
75
M
120
6
3
12.45
1
Intra operative Pulse Chart - Group BA
I
s.no
0 min
1 min
2 min
5min
10 mins
15 mins
30 mins
60 mins
90 mins
120 mins
1
88
88
89
86
89
91
86
88
94
90
2
88
90
90
88
86
82
88
77
77
76
3
88
88
90
90
86
87
90
92
84
89
4
80
80
84
89
85
84
76
84
85
87
5
84
86
87
80
82
76
72
80
86
89
6
82
86
88
96
91
93
84
88
86
89
7
86
86
88
78
73
73
70
74
73
74
8
82
84
82
78
73
68
68
80
86
85
9
86
91
96
90
88
90
92
66
70
77
10
82
86
91
87
91
93
92
85
84
88
11
92
90
89
88
94
91
85
87
94
98
12
98
98
99
99
96
92
89
98
91
97
13
90
94
97
87
85
89
98
87
92
90
14
84
81
83
87
89
93
88
94
94
85
15
80
78
80
85
89
84
90
81
87
87
16
100
104
106
98
95
99
102
98
96
94
17
73
76
75
79
82
85
84
75
76
81
18
86
89
87
90
94
88
83
88
89
81
19
81
87
85
88
90
94
84
79
84
85
20
89
93
97
92
94
88
93
89
88
87
Intra operative Pulse Chart - Group BC
I
s.no
0 min
1 min
2 min
5min
10 mins
15 mins
30 mins
60 mins
90 mins
120 mins
1
85
89
91
97
92
95
86
88
87
89
2
90
94
98
99
96
98
104
88
89
94
3
108
110
104
114
116
122
113
102
101
104
4
86
86
88
86
84
83
86
85
71
79
5
96
98
99
101
104
99
92
97
96
92
6
84
87
83
91
95
94
86
82
88
93
7
70
68
66
65
60
63
62
73
71
75
8
76
78
83
90
79
74
76
86
85
89
9
82
84
84
82
94
96
86
94
89
85
10
92
92
94
93
95
98
102
87
85
87
11
106
106
107
106
101
104
93
96
98
96
12
80
85
88
89
85
83
93
91
89
84
13
94
94
96
105
106
102
94
95
93
90
14
86
89
90
83
88
85
86
76
81
85
15
78
84
86
85
88
83
87
86
84
87
16
75
77
78
85
88
94
87
80
85
91
17
106
109
104
107
104
101
90
94
93
99
18
82
86
89
88
82
87
93
88
86
82
19
89
82
86
95
92
97
83
91
82
85
20
72
77
79
81
84
80
77
89
85
80
Intra operative systolic BP Chart - Group BA
I
S.no
o min
1 min 
2 min
5 min
10 mins
15 mins
30 mins
60 mins
90 mins
120 mins
1
130
130
130
130
132
126
120
114
115
110
2
126
126
126
130
126
122
114
126
110
110
3
140
140
140
130
130
136
128
130
124
130
4
120
120
120
130
126
122
116
124
118
120
5
140
140
138
130
124
126
120
126
130
130
6
120
114
118
114
108
104
120
116
112
120
7
130
124
124
120
120
117
98
114
120
118
8
124
126
120
120
112
108
106
116
114
118
9
136
137
132
139
138
130
117
124
119
120
10
120
124
118
114
108
110
114
116
112
106
11
110
112
108
106
114
118
110
108
118
112
12
120
114
110
102
114
108
106
110
116
122
13
116
118
116
112
104
106
114
120
122
120
14
114
118
110
114
108
112
120
108
112
120
15
110
114
116
118
112
110
114
118
114
120
16
128
124
128
120
112
116
110
114
122
118
17
120
120
126
118
112
110
108
112
116
116
18
118
120
126
120
124
120
114
118
118
114
19
110
112
114
110
116
118
116
114
114
120
20
116
118
110
106
104
108
108
116
120
114
Intra operative systolic BP Chart - Group BC
I
S.no
o min
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2 min
5 min
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60 mins
90 mins
120 mins
1
132
136
136
130
138
140
128
124
126
130
2
120
120
126
124
130
126
136
114
122
120
3
130
140
132
144
148
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132
140
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4
130
130
130
124
125
120
132
130
136
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5
126
126
130
132
124
122
120
124
126
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6
110
112
112
120
116
114
124
128
116
110
7
120
120
124
124
116
110
114
116
120
116
8
120
126
124
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120
126
120
118
120
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9
140
140
136
124
126
130
120
122
132
136
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140
140
146
130
130
136
140
120
120
126
11
130
130
136
150
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138
140
140
138
132
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110
110
116
122
126
116
120
112
116
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140
140
146
140
146
138
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130
130
138
14
120
120
132
126
126
120
124
116
120
114
15
130
134
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132
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124
112
124
120
132
16
116
120
122
120
126
116
110
126
126
116
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120
114
114
124
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120
114
124
126
120
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120
122
126
110
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124
120
120
116
124
19
110
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114
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114
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110
112
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114
108
110
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Intra operative diastolic BP Chart - Group BA
s.n
o
0 
min 
1 
min
2 
min
5 
min
s
10 
mins
15 
mins
30 
mins
60 
mins
90 
mins
120 
mins
1 80 80 80 80 78 74 78 78 70 74
2 80 80 80 80 78 74 78 78 70 74
3 90 90 90 80 80 82 86 86 84 90
4 80 80 80 82 78 76 74 74 70 70
5 86 86 90 74 76 74 74 82 76 80
6 70 74 78 74 70 68 76 72 70 78
7 90 88 90 80 80 82 66 76 80 84
8 80 80 82 80 76 74 70 80 74 82
9 84 81 82 80 81 79 74 81 82 78
10 70 72 76 72 68 74 80 82 74 70
11 80 78 78 70 76 74 70 70 6 76
12 80 80 84 74 76 80 72 74 78 74
13 70 72 78 70 66 68 72 78 78 84
14 72 70 76 70 66 70 76 70 70 72
15 80 84 84 76 72 70 70 74 76 76
16 74 72 72 70 68 72 70 72 76 80
17 80 82 82 78 74 76 74 70 74 78
18 70 74 76 72 70 72 76 70 72 78
19 74 72 76 70 70 76 72 68 70 70
20 80 84 80 78 74 70 66 72 80 80
8
Intra operative diastolic BP Chart - Group BC
s.n
o
0 
min 
1 
min
2 
min
5 
min
s
10 
mins
15 
mins
30 
mins
60 
mins
90 
mins
120 
mins
1 76 80 82 80 84 84 72 76 80 84
2 80 80 80 88 86 88 84 80 82 82
3 86 90 86 88 92 96 82 86 90 86
4 86 84 86 84 80 84 94 74 76 74
5 80 82 84 88 78 74 70 78 80 78
6 70 74 74 78 86 80 72 70 70 76
7 80 80 82 78 72 70 70 78 84 80
8 80 84 88 86 84 86 80 74 84 84
9 90 90 82 80 84 82 80 86 84 88
10 90 90 90 84 86 88 90 78 80 80
11 90 90 90 90 86 84 86 90 82 84
12 70 72 76 70 78 70 84 80 72 78
13 90 90 84 84 82 84 76 84 80 84
14 80 80 86 80 80 82 84 74 76 72
15 80 80 84 76 72 70 82 80 84 86
16 70 74 78 80 74 82 80 76 72 78
17 80 80 84 74 78 86 80 74 82 76
18 70 70 74 68 76 72 80 74 70 70
19 76 76 80 84 82 74 70 76 80 84
20 70 76 76 70 66 68 74 80 74 66
 Post Operative Pulse Chart - Group BA
s.n
o
0 
min
15 
mins
30 
mins
1 
hr
2 
hr
3 
hr 
4 
hr
6 
hr 
12 
hr
2
4 
hr
1 87 86 84 80 80 86 84 85 81 84
2 78 70 76 82 86 85 87 90 84 82
3 88 84 87 89 90 92 88 86 85 88
4 87 84 80 76 79 74 78 82 84 81
5 86 86 89 84 81 85 86 84 88 86
6 89 84 82 87 85 86 88 82 84 81
7 73 76 74 70 72 74 70 76 75 73
8 80 84 86 85 87 84 81 85 88 87
9 70 73 77 79 75 80 82 81 87 85
10 94 96 93 90 87 84 88 85 89 90
11 98 95 90 86 88 85 89 91 93 90
12 91 96 97 94 98 95 97 94 92 87
13 96 92 90 87 89 85 86 84 88 89
14 94 91 85 86 88 83 87 89 85 88
15 82 85 87 84 80 78 75 79 81 77
16 91 94 98 99 95 97 98 95 96 94
17 81 84 83 85 82 77 79 74 74 79
18 86 81 78 75 76 79 74 72 79 75
19 88 85 84 86 88 90 86 85 79 82
20 87 84 82 88 89 85 79 76 83 85
8
Post Operative Pulse Chart - Group BC
s.n
o
0 
min
15 
mins
30 
mins
1 
hr
2 
hr
3 
hr 
4 
hr
6 
hr 
12 
hr
2
4
 
h
r
1 102 106 101
10
5 98 94 99 98 96
9
4
2 84 89 91 94 88 83 81 87 85
8
4
3 102 104 104 98 96 90 87 80 82
8
4
4 76 79 84 88 85 83 82 85 86
8
1
5 99 96 95 92 98 96 91 95 97
9
3
6 88 90 93 91 87 86 88 84 82
8
6
7 77 74 71 75 79 79 78 74 70
6
8
8 87 89 85 81 86 85 88 83 81
8
5
9 84 87 88 90 84 82 87 81 85
8
8
10 85 86 89 81 88 84 86 85 82
8
6
11 91 94 97 99 96
10
2
10
4
10
6 101
9
7
12 89 85 84 82 86 84 81 85 86
8
2
13 93 90 84 87 85 81 79 87 85
9
0
14 79 83 81 85 82 86 85 82 84
8
0
15 87 84 81 85 88 84 82 86 82
8
5
16 85 87 91 86 82 85 80 78 75
7
9
17 93 97 99 95 96 92 90 87 84
8
8
18 82 86 81 80 77 83 85 88 82
8
0
19 88 90 94 91 84 82 87 85 88
8
2
20 85 88 80 76 75 79 83 85 81
8
6
Post Operative Systolic BP Chart - Group 
BA
s.n
o
0 
min
15 
mins
30 
mins
1 
hr
2 
hr
3 
hr
4 
hr
6 
hr
12 
hr 2
1 110 116 116
12
0
12
0
12
2
13
0
14
0 132 1
2 110 110 110
11
6
11
6
12
0
12
0
12
0 126 1
3 136 140 140
14
0
13
6
14
0
13
2
13
0 134 1
4 120 124 128
13
0
13
0
13
0
12
4
12
0 120 1
5 130 130 130
13
0
14
0
13
2
13
6
13
0 130 1
6 120 120 114
10
8
11
6
12
4
11
8
10
4 110 1
7 120 120 118
12
4
11
6
11
4
11
2
11
4 120 1
8 116 120 114
11
8
12
4
12
0
11
4
11
6 120 1
9 126 120 116
12
2
11
8
12
0
11
2
11
0 116 1
10 110 116 114
12
0
12
4
12
2
11
4
11
0 116 1
11 112 118 124
12
0
12
6
11
8
10
8
11
4 116 1
12 116 120 122
11
6
11
0
10
8
11
4
12
2 126 1
13 120 120 114
11
8
11
0
10
8
11
0
11
4 122 1
14 112 114 120
11
4
10
8
11
0
11
0
11
2 118 1
15 120 124 126
11
4
11
6
11
2
12
2
11
6 112 1
16 124 124 120
11
2
11
0
11
6
11
4
12
2 124 1
17 116 120 114
11
2
12
0
12
2
11
6
12
4 126 1
18 112 114 120
12
2
11
2
11
8
12
2
12
6 122 1
19 118 120 120
11
2
11
6
12
0
12
2
11
6 110 1
20 114 114 118
12
4
13
0
12
2
13
4
12
6 120 1
7Post Operative Systolic BP Chart - Group 
BC
s.n
o
0 
min
15 
mins
30 
mins
1 
hr
2 
hr
3 
hr
4 
hr
6 
hr
12 
hr 2
1 140 140 140
14
0
14
0
14
6
14
4
13
6 136 1
2 114 118 120
12
4
11
2
11
6
12
0
12
8 126 1
3 130 130 124
12
0
12
0
12
6
13
0
13
0 130 1
4 134 128 122
11
4
11
8
11
6
12
2
12
4 130 1
5 126 130 124
13
0
13
2
12
6
12
2
12
0 118 1
6 116 120 110
10
8
10
4
11
2
12
4
13
0 120 1
7 120 112 116
11
0
11
6
11
2
12
2
12
4 120 1
8 120 120 126
13
0
12
4
12
0
12
0
12
6 124 1
9 136 132 140
13
0
12
6
12
2
12
6
13
0 132 1
10 120 120 120
12
6
12
0
13
0
13
0
12
4 122 1
11 136 140 140
13
6
13
6
14
0
14
0
14
0 140 1
12 116 120 126
13
0
12
2
12
0
12
2
11
6 126 1
13 130 134 138
14
0
13
2
12
6
12
8
13
0 132 1
14 120 112 114
12
2
12
6
13
0
13
2
12
4 130 1
15 126 132 130
13
0
12
6
12
4
12
2
12
8 132 1
16 126 122 116
12
0
12
4
11
2
11
0
11
4 122 1
17 126 124 120
12
4
12
6
13
0
13
6
12
6 124 1
18 116 114 120
12
6
12
4
13
6
12
4
11
6 112 1
19 126 120 124
11
6
11
2
11
0
11
6
12
2 128 1
20 120 112 108
10
4
11
6
11
0
11
4
12
0 126 1
Post Operative Diastolic BP Chart - Group 
BA
s.n
o
0 
min 
15 
mins
30 
mins
1 
hr
2 
hr
3 
hr
4 
hr
6 
hr
12 
hr
2
4 
hr
1 70 70 74 80 84 86 86 80 84 80
2 74 74 78 80 82 80 80 84 84 80
3 90 90 90 90 84 88 86 80 88 86
4 70 70 76 78 82 84 80 76 80 82
5 76 80 86 80 86 78 80 76 80 80
6 78 78 80 74 76 82 82 70 72 84
7 80 80 84 86 78 74 70 76 84 78
8 80 82 74 82 86 76 78 80 80 86
9 82 74 78 84 84 82 78 76 74 72
10 72 76 68 72 76 76 80 78 72 80
11 76 80 80 84 82 80 72 76 70 78
12 78 80 74 70 70 68 66 72 78 84
13 76 80 72 76 72 68 70 82 84 78
14 70 76 72 70 66 70 74 78 72 70
15 76 74 70 72 78 74 80 74 78 76
16 86 82 76 78 74 78 72 80 86 84
17 78 82 76 78 84 84 78 82 86 82
18 74 78 76 74 68 72 84 80 76 78
19 70 74 76 74 78 78 72 74 76 74
20 80 82 78 82 86 84 78 72 74 66
YPost Operative Diastolic BP Chart - Group 
BC
s.n
o
0 
min 
15 
mins
30 
mins
1 
hr
2 
hr
3 
hr
4 
hr
6 
hr
12 
hr
2
4 
hr
1 90 90 90 90 90 82 88 90 84 80
2 80 76 82 86 76 74 78 82 84 80
3 86 90 86 84 80 84 82 80 80 84
4 82 74 80 84 80 78 80 86 90 90
5 80 82 78 80 84 78 70 72 70 78
6 70 74 76 72 78 80 86 78 72 70
7 84 76 80 72 76 74 80 84 82 84
8 84 84 86 86 78 80 80 82 84 86
9 90 86 90 84 78 80 84 84 88 88
10 80 80 86 84 88 90 90 86 84 86
11 80 88 90 84 90 82 90 90 90 90
12 72 74 78 80 74 70 70 68 74 76
13 80 82 84 88 78 74 70 76 80 86
14 80 76 72 78 80 80 84 86 80 82
15 86 86 84 88 82 76 70 74 80 82
16 72 74 78 80 82 76 78 82 80 80
17 82 76 82 72 78 82 84 80 88 84
18 70 76 80 72 78 82 84 84 74 80
19 86 82 80 74 78 74 72 76 82 76
20 74 70 66 68 72 76 74 78 74 70
7
Saturation Chart - Group BA
s.n
o
0 
min 
5 
mins
10 
mins 
15 
mins
30 
mins
1 
hr 
2 
hr
4 
hr 
6 
hr 
12 
hr
24 
hr
1 100 100 100 100 100
10
0
10
0
10
0
10
0 100 100
2 100 100 100 100 100
10
0
10
0
10
0
10
0 100 100
3 100 100 100 100 100
10
0
10
0
10
0
10
0 100 100
4 100 100 100 100 100
10
0
10
0
10
0
10
0 100 100
5 100 100 100 100 100
10
0
10
0
10
0
10
0 100 100
6 99 99 99 99 98 98 99 99 99 99 99
7 100 100 100 100 100
10
0
10
0
10
0
10
0 100 100
8 100 100 100 100 100
10
0
10
0
10
0
10
0 100 100
9 100 100 100 100 100
10
0
10
0
10
0
10
0 100 100
10 100 100 100 100 100
10
0 98 98 98 100 100
11 98 98 98 99 99 99 99 99 99 99 99
12 99 99 99 99 99 99 99 99 99 99 99
13 100 100 100 100 100
10
0
10
0
10
0
10
0 100 100
14 99 99 99 97 98 98 97 98 98 99 99
15 99 99 99 99 99 99 99 99 99 99 99
16 98 98 98 98 98 97 98 98 98 98 98
17 100 100 100 100 100
10
0
10
0
10
0
10
0 100 100
18 99 99 99 99 99 99 99 99 99 99 99
19 99 99 99 99 99 99 99 99 99 99 99
20 99 99 99 99 99 99 99 99 99 99 99
9
Saturation Chart - Group BC
s.n
o
0 
min 
5 
mins
10 
mins 
15 
mins
30 
mins
1 
hr 
2 
hr
4 
hr 
6 
hr 
12 
hr
24 
hr
1 98 99 99 99 99 99 99
10
0
10
0 100 100
2 100 100 100 100 100
10
0
10
0
10
0
10
0 100 100
3 100 100 100 100 100
10
0
10
0
10
0
10
0 100 100
4 100 100 100 100 100
10
0
10
0
10
0
10
0 100 100
5 99 99 99 99 99 99 99 99 99 99 99
6 100 100 100 100 100
10
0
10
0
10
0
10
0 100 100
7 100 100 100 100 100
10
0
10
0
10
0
10
0 100 100
8 100 100 100 100 100
10
0
10
0
10
0
10
0 100 100
9 100 100 100 100 100
10
0
10
0
10
0
10
0 100 100
10 100 100 100 100 100
10
0
10
0
10
0
10
0 100 100
11 100 100 100 100 100
10
0
10
0
10
0
10
0 100 100
12 99 99 99 99 99 99 99 99 99 99 99
13 100 100 100 100 100
10
0
10
0
10
0
10
0 100 100
14 100 100 100 100 100
10
0
10
0
10
0
10
0 100 100
15 98 98 98 98 98 98 98 98 98 98 98
16 99 99 99 99 99 99 99 99 99 99 99
17 100 100 100 100 100
10
0
10
0
10
0
10
0 100 100
18 99 99 99 99 99 99 99 99 99 99 99
19 99 99 99 99 99 99 99 99 99 99 99
20 99 99 99 99 99 99 99 99 99 99 99
